Cost-Effectiveness of Vaccination with the 20-Valent Pneumococcal Conjugate Vaccine in the Italian Adult Population

Cost-Effectiveness of Vaccination with the 20-Valent Pneumococcal Conjugate Vaccine in the Italian Adult Population

The availability of a new 20-valent pneumococcal conjugate vaccine (PCV) makes it appropriate to assess its cost-effectiveness. This was evaluated by adopting the Italian National Health Service perspective, using a cost consequences Markovian model. The expected effects of vaccination with 20-valen...

Full description

Bibliographic Details
Main Authors: Barbara Polistena, Giancarlo Icardi, Andrea Orsi, Federico Spandonaro, Roberto Di Virgilio, Daniela d’Angela
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Vaccines
Subjects:
vaccines
immunization
cost consequences
cost-effectiveness
cost-utilities
Online Access:https://www.mdpi.com/2076-393X/10/12/2032

Similar Items

Similar Items